Clinical Trial Update: Effect of Dapagliflozin on Vascular Functions in Patients With Type 2 Diabetes Compared to Gliclazide [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing dapagliflozin to gliclazide for effects on vascular function in type 2 diabetes patients, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Gliclazide (gliclazide)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Diabetes | Phase 4 | Status: COMPLETED